Monthly News Roundup - September 2016

Amjevita, a Biosimilar to Humira, Wins FDA Approval Amgen ’s Amjevita (adalimumab-atto) is the first adalimumab (Humira) biosimilar approved by the U.S. Food and Drug Administration (FDA) and is used for the treatment of seven inflammatory...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news